Market Overview

UPDATE: Bard to Purchase Rochester Medical at $20/Share, or ~$262M Deal

Share:
Related ROCM
C.R. Bard Rises After Q3 Earnings Beat (BCR)
Market Wrap For Wednesday, September 4: Markets Increase Slightly As M&As Continue To Rise
Related BCR
Stocks Going Ex Dividend The Third Week Of July
What Drove Becton, Dickinson (BDX) to a New 52-Week High?

Rochester Medical Corporation (NASDAQ: ROCM) today announced it has entered into a definitive merger agreement with C. R. Bard, Inc. (NYSE: BCR) at a price of $20 per share, or approximately $262 million in the aggregate. The Rochester Medical Board of Directors unanimously approved the agreement and will recommend that the Company's shareholders approve the transaction.

Under the terms of the merger agreement, Rochester Medical shareholders will receive $20 in cash for each share that they hold at the closing of the merger, representing a 37 percent premium over the Company's average closing price during the 90 trading days ended September 3, 2013. The acquisition is subject to certain closing conditions specified in the definitive agreement, including regulatory approvals and the approval of Rochester Medical's shareholders. The transaction is expected to close in the fourth calendar quarter of 2013.

Posted-In: News M&A Hot

 

Related Articles (ROCM + BCR)

View Comments and Join the Discussion!
Loading...
Loading...